Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Delieva, L. Dolinina, V. Trofimov (St. Petersburg, Russian Federation). The effect of smoking on the activity of inflammatory markers in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 4272

Member's Comments

No comment yet.

Related content which might interest you: Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 Cytotoxic activity and oxidative DNA damage in smoking asthmatics versus COPD patients Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Proteinase-inhibitor system state in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007 Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Sputum biomarkers of inflammation in smokers and subjects with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Comparison of osteoporosis in male smokers with or without COPD Source: International Congress 2016 – Smoking-related diseases Year: 2016 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007 Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms? Source: Annual Congress 2005 - Lung structure: current concepts Year: 2005 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015